The ongoing Bundibugyo virus outbreak in the Democratic Republic of the Congo dominates trader sentiment, with over 5,000 confirmed cases and more than 2,300 deaths reported by mid-August 2026, already surpassing the country's prior record. Rapid geographic expansion across six provinces, unidentified transmission chains, and the absence of approved vaccines or treatments for this strain create sustained momentum for additional cases through year-end. Imported detections in France and resolved clusters in Uganda highlight the potential for sporadic international spread, though WHO assessments rate broader global risk as low. Neighboring countries face elevated exposure due to porous borders and conflict zones complicating containment, while upcoming factors like experimental vaccine trials and scaled surveillance could shift probabilities if transmission slows before December. Traders weigh the outbreak's unprecedented pace against historical patterns of eventual containment in similar settings.